#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma refractory Small cell lung cancer recurrent Ocular lymphoma Hereditary angioedema with C1 esterase inhibitor deficiency Focal segmental glomerulosclerosis Arrhythmogenic right ventricular dysplasia Scedosporium infection Alport's syndrome Leukocyte adhesion deficiency type I Oesophageal adenocarcinoma Malignant glioma Acute lymphocytic leukaemia Non-renal cell carcinoma of kidney Dementia Alzheimer's type Pulmonary fibrosis More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis – Diagnostics Thrombotic thrombocytopenic purpura – Treatment Vascular malformation – Life with Disease Pemphigus – Basic Information Pulmonary sarcoidosis – Diagnostics Adrenocortical carcinoma – Trials in Disease Mastocytosis – Trials in Disease Epidermolysis bullosa – Trials in Disease Pulmonary fibrosis – Life with Disease Undifferentiated sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Capsaicin Bhv-7000 Levocetirizine Dihydrochloride LTG-001 Piperacillin Sodium Umeclidinium Bromide Retifanlimab Redasemtide Seralutinib Radotinib Dihydrochloride Oms906 Islatravir Ertugliflozin L-Arginine Hydrochloride Cannabidiol Lorlatinib Bexmarilimab Levofloxacin SODIUM SELENITE PENTAHYDRATE ALXN1920 More therapies…

    Learn about Your Condition

    Thyroid cancer Bronchopulmonary aspergillosis Paraesthesia Implantation complication Open angle glaucoma Diffuse large B-cell lymphoma Renal cancer T-cell lymphoma PIK3CA-activated mutation Synovial sarcoma metastatic Laryngeal cancer Mesothelioma malignant Neurodevelopmental disorder Angiopathy Oxygen therapy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. INKARD Sp. Z O.O. Sp. JAWNA

INKARD Sp. Z O.O. Sp. JAWNA

Hetmanska 1A/12, Poznan, 60-254, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!